Trial intelligence / Profile preview

Remimazolam tosilate for procedural sedation during induction of general anesthesia

ChiCTR2000032846Phase 4Not yet recruiting

Sponsor
Sichuan Bayi Rehabilitation Center
Start
Jun 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, single-blind trial of remimazolam (2 arms), sponsored by Sichuan Bayi Rehabilitation Center. Primary endpoints: Vital signs, Bispectral Index and 1 more. Planned start Jun 2020; status: not yet recruiting.

02

Drugs

remimazolam

Beyond the preview

Go deeper on ChiCTR2000032846.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000032846.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call